RSS09-2008 (September 2008)

Topical Imiquimod Therapy for Actinic Keratosis Is Long-Term Clearance a Realistic Benefit?

| September 16, 2008 | 0 Comments

by James Q. Del Rosso, DO, FAOCD Dr. James Del Rosso, DO, FAOCD, is Dermatology Residency Director, Valley Hospital Medical Center; Clinical Associate Professor (Dermatology), University of Nevada School of Medicine, Las Vegas, Nevada; and Associate Professor (Dermatology), Touro University College of Osteopathic Medicine, Henderson, Nevada.

Continue Reading

The Role of Diet in Acne and Rosacea

| September 16, 2008 | 1 Comment

by Jonette E. Keri, MD, PhD, and Adena E. Rosenblatt Department of Dermatology, University of Miami Miller School of Medicine, Miami, Florida Disclosure: The authors identified no conflicts of interest.

Continue Reading

Lasers and Light Treatments for Acne Vulgaris Promising Therapies

| September 3, 2008 | 0 Comments

Therapeutic and Aesthetic Uses of Photodynamic Therapy Part two of a five-part series by Michael H. Gold, MD Medical Director, Gold Skin Care Center and The Laser & Rejuvenation Center, Nashville, Tennessee Disclosure: Dr. Gold is a consultant to, speaks for, and receives honoraria from Pharos Life. Address correspondence to: Michael H. Gold, MD, Gold [...]

Continue Reading

A Practical Approach to Screening Psoriasis Patients for Therapy with Biologic Agents

| September 3, 2008 | 0 Comments

by Joshua A. Zeichner, MD Author: Dr. Zeichner is a Chief Resident, Department of Dermatology, Mount Sinai Medical Center, New York, New York. Section Editors: Jerry Tan, MD, FRCPC, is Adjunct Professor, University of Western Ontario, London, Ontario; President, Windsor Clinical Research Inc., Windsor, Ontario; and Consultant, Windsor Regional Hospital, Windsor, Ontario, Canada. He is [...]

Continue Reading

Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide/Clindamycin Combination Product

| September 3, 2008 | 0 Comments

An Investigator-Blind, Randomized, Parallel-Group Study by [a]Lawrence J. Green, MD, and [b]James Q. Del Rosso, DO, FAOCD [a]George Washington University, Washington, DC; [b]Clinical Associate Professor (Dermatology), University of Nevada School of Medicine and Touro University College of Osteopathic Medicine; Dermatology Residency Director, Valley Hospital Medical Center and Las Vegas Skin and Cancer Clinics, Las Vegas [...]

Continue Reading

What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?

| September 3, 2008 | 0 Comments

by Mark Lebwohl, MD Author: Dr. Mark Lebwohl, MD, is Professor and Chairman, Department of Dermatology, The Mount Sinai School of Medicine, New York, NY. Section Editor: Dr. James Del Rosso, DO, FAOCD, is Dermatology Residency Director, Valley Hospital Medical Center; Clinical Associate Professor (Dermatology), University of Nevada School of Medicine, Las Vegas, Nevada; and [...]

Continue Reading